Jul 11, 2007
Myomo e100 NeuroRobotic System
US company Myomo has announced that the e100 NeuroRobotic System, a technology designed to help in the rehabilitation process of patients by "engaging and reinforcing both neurological and motor pathways," has received FDA clearance to market.
How it Works
- Patient's brain is the controller: When a patient attempts movement during therapy, their muscles contract and electrical muscle activity signals fire
- Non-invasive sensing: An EMG sensor sits on the skin's surface to detect and continuously monitor a person's residual electrical muscle activity
- Proprietary system software: Advanced signal processing software filters and processes the user's EMG signal, and then forwards the data to a robotic device
- Proportional assistance: Portable, wearable robotics use the person's EMG signal to assist with desired movement; power assistance is customized to patient ability with Myomo's real-time adjustable control unit.
Product page: Myomo e100 NeuroRobotic System ...